Tandem Diabetes Care hits 7-year low on issuing voluntary device correction for certain insulin pumps

Shares of diabetes device maker Tandem Diabetes Care TNDM.O fall as much as 26.1% to a more than 7-year low of $9.98

TNDM says it issued a voluntary correction for certain insulin pumps, citing a speaker malfunction that could halt insulin delivery and disrupt communication with glucose monitoring devices

Co reports 700 confirmed adverse events and 59 injuries associated with the issue

No deaths had been linked to the problem with the t:slim X2 insulin pumps - TNDM

Including session moves, stock down 71.4% YTD